A drug company, a psychiatrist, and an inexplicable failure to disclose conflicts of interest.

Charles B. Nemeroff, M.D., Ph.D., is a psychiatrist at Emory University alleged by congressional investigators to have failed to report a third of the $2.8 million (or more) he received in consulting fees from pharmaceutical companies whose drugs he was studying.
Why would congressional investigators care? For one thing, during the period of time when Nemeroff received these consulting fees, he also received $3.9 million from NIH to study the efficacy of five GlaxoSmithKline drugs in the treatment of depression. When the government ponies up money for scientific research, it has an interest in ensuring that the research will produce reliable knowledge.
GlaxoSmithKline, of course, has an interest in funding studies that show that its drugs work really well.

Continue reading

Schwarzenegger signs Researcher Protection Act of 2008.

The past couple years in California have been scary ones for academic researchers who conduct research with animals (as well as for their neighbors), what with firebombs, home invasions, significant intentional damage to their properties and threats to their safety.
In response to a ratcheting up of attacks from animals rights groups, universities have lobbied for the Researcher Protection Act of 2008, which Governor Arnold Schwarzenegger signed into law on September 28.

Continue reading

Freelance chemistry for fun and (illegal) profit.

You know how graduate students are always complaining that their stipends are small compared to the cost of living? It seems that some graduate students find ways to supplement that income … ways that aren’t always legal. For example, from this article in the September 8, 2008 issue of Chemical & Engineering News [1]:

Jason D. West, a third-year chemistry graduate student at the University of California, Merced, was arraigned last month on charges of conspiring to manufacture methamphetamine, manufacturing methamphetamine, and possessing stolen property. West allegedly stole approximately $10,000 worth of equipment and chemicals from the university to make the illegal drug.
West, 36, pleaded not guilty to the charges and as of press time was in jail on $1 million bail. Police have found materials traced to West at three different meth labs and in one vehicle, says Tom MacKenzie of the Merced County Sheriff’s Department.

The police ended up arresting West following an investigation by UC-Merced campus police of the whereabouts of a vacuum pump that went missing from West’s graduate lab. Graduate students take note: your advisor will miss that expensive piece of lab equipment.

Continue reading

Gimme the money — hold the oversight.

From time to time on this blog, we discuss the obligation scientists assume by virtue of accepting public money to fund their research. These obligations may include sharing knowledge with the public (since public money helped make that knowledge). And they also include playing by the public’s rules as enshrined in various federal regulations concerning scientific research.
If a scientist takes public money, she expects there will be some public oversight. That’s just how it goes.
Of course, working from this mindset makes it much harder for me to fathom how someone (say a Secretary of the Treasury) could ask for a big chunk of public money (say $700 billion) with no oversight whatsoever. Indeed, in trying to make sense of such a request, I find myself entertaining some pretty odd hypotheses:

Continue reading

Important advice for academic job-seekers at all levels.

Do not claim to have earned a degree (or degrees) that you did not in fact earn.
Degree-granting institutions maintain records of degree recipients. Eventually, chances are good that someone will check.
And even if your talents are worth more to your position than a degree could be, your dishonesty will be held against you.
Go with talent and integrity over talent and pretend credentials. Those who employ you will appreciate not being played for chumps.

What’s up with the market?

Not the financial market, but the market for highly trained folks in science, technology, engineering, and mathematics (STEM). In particular, why do people keep talking about the need for a larger talent pool in STEM when so many Ph.D.s and postdocs are having a rough time finding permanent positions?
Today, Inside Higher Ed has an article about what demographer Michael S. Teitelbaum of the Alfred P. Sloan Foundation makes of this apparently paradoxical state of affairs:

Continue reading

Science Debate 2008: It’s not the candidates’ answers that leave me cold

… but the questions that they were answering!
Regular readers will know (from these posts, among others) that I think the extent to which presidential candidates have gotten right with science (or with reliable advisers on same) is important information for voters to have.
Indeed, I was hoping to get some nourishing information (building an informed electorate and healthy democracy with 12 vitamins and minerals!) when I checked out Obama’s and McCain’s answers to the Science Debate 2008 questions. And, while it is possible to glean information about McCain’s and Obama’s attitudes toward science and its role in the public sphere from these answers, there was rather less straight talk than I had hoped.
The reason for that, I think, has a lot to do with the 14 questions actually put before the candidates — questions, Michael Eisen points out, that sidestep the science-y heart of the matter for all-too-familiar political territory:

Continue reading

Medical research with ‘legacy samples’ raises ethical questions.

In the July 18, 2008 issue of Science, I noticed a news item, “Old Samples Trip Up Tokyo Team”:

A University of Tokyo team has retracted a published research paper because it apparently failed to obtain informed consent from tissue donors or approval from an institutional review board (IRB). Other papers by the same group are under investigation by the university. Observers believe problems stem in part from guidelines that don’t sufficiently explain how to handle samples collected before Japan established informed consent procedures.

The samples in question were “legacy samples”, samples that had been previously collected for other research projects. The fact that these samples were collected before the institution of the rules for research with human subjects to which Japanese researchers are now bound complicates the ethical considerations for the researchers.

Continue reading